BiopSensen offers solutions and services for liquid biopsy monitoring of cancer. When the selection of available medications are increasing, more frequent monitoring helps the oncologists to respond more quickly, if the therapy is not satisfactory or if possible drug resistance is raised. As a result, the patient will receive the correct treatment faster. Cancer medications are often very expensive, in addition, cancer medications are either really effective or not working at all. That is why it is really important to get the medication right as soon as possible. Therefore, screening for cancer with BiopSense is a very effective way to improve the quality of cancer treatments and reduce costs.
Sample transfer is a bottleneck for the global availability of liquid biopsy services and also impedes the business of our company. Therefore BiopSense develops automated extraction and transfer cartridge of blood-based biomarkers (DNA, RNA, cells, proteins). This enables frequent sample acquisition and analysis, as well as facilitates the expansion of the international liquid biopsy service business across borders and continents, independently of the laboratory workforce situation in the customer hospitals or conditions of the sample transfer.
Business and technology development
Chief physician, Oncology